These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9798537)

  • 1. Left ventricular hypertrophy and parathyroid hormone: a causal connection?
    Schlüter KD; Piper HM
    Cardiovasc Res; 1998 Aug; 39(2):523-4. PubMed ID: 9798537
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between some humoral factors and left ventricular hypertrophy in essential hypertension.
    Hui Y; Hao Y; Chen X; Jing S; Dai Z
    Chin Med J (Engl); 1996 Nov; 109(11):885-7. PubMed ID: 9275376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The fractional calcium composition and the content of calcium-regulating hormones in the blood plasma of hypertension patients].
    Polivoda SN; Vizir VA
    Lik Sprava; 1994; (5-6):25-9. PubMed ID: 7831903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clues for understanding the pathogenesis of left ventricular hypertrophy in chronic uremia.
    Cannella G; Paoletti E
    Int J Artif Organs; 1998 Jul; 21(7):378-83. PubMed ID: 9745991
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiotrophin: its importance as a pathogenetic factor and as a measure of left ventricular hypertrophy.
    Schmidt BM; Schmieder RE
    J Hypertens; 2005 Dec; 23(12):2151-3. PubMed ID: 16269955
    [No Abstract]   [Full Text] [Related]  

  • 6. [Is leptin an independent risk factor for development of left ventricular hypertrophy in obese hypertensive patients?].
    Kiliç T
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):347-9. PubMed ID: 18849225
    [No Abstract]   [Full Text] [Related]  

  • 7. Nutritional modulation of parathyroid hormone secretion may influence risk for left ventricular hypertrophy.
    McCarty MF
    Med Hypotheses; 2005; 64(5):1015-21. PubMed ID: 15780503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    Bratisl Lek Listy; 2004; 105(10-11):368-73. PubMed ID: 15658577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and biventricular hypertrophy in essential hypertension.
    Grossman E
    J Hum Hypertens; 2009 Mar; 23(3):211-2. PubMed ID: 19052567
    [No Abstract]   [Full Text] [Related]  

  • 10. Parathyroid hormone is associated with the LV mass after aortic valve replacement.
    Laflamme MH; Mahjoub H; Mahmut A; Boulanger MC; Larose E; Pibarot P; Mathieu P
    Heart; 2014 Dec; 100(23):1859-64. PubMed ID: 25095827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma catecholamine release-inhibitory peptide catestatin in patients with essential hypertension.
    Meng L; Ye XJ; Ding WH; Yang Y; Di BB; Liu L; Huo Y
    J Cardiovasc Med (Hagerstown); 2011 Sep; 12(9):643-7. PubMed ID: 21508845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The interrelationship between humoral factors and the indices of left ventricular myocardial hypertrophy in hypertension].
    Selivonenko VG; Sholokh SG; Morozov AI
    Lik Sprava; 1992 Jun; (6):59-61. PubMed ID: 1333680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of the contents of insulin and vasoactive intestinal peptides in the patients with primary hypertension].
    Xu L; Su H; Wang R; Tong M
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 1997 Feb; 13(1):93-4. PubMed ID: 10074335
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitamin D and cardiovascular disease will it live up to its hype?
    Lavie CJ; Lee JH; Milani RV
    J Am Coll Cardiol; 2011 Oct; 58(15):1547-56. PubMed ID: 21958881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parathormone and left ventricular hypertrophy].
    Massimetti C; Achilli P; Zampi G; Feriozzi S
    G Ital Nefrol; 2014; 31(6):. PubMed ID: 25504162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of left ventricular hypertrophy and its progression in high-flux haemodialysis.
    Kong CH; Farrington K
    Blood Purif; 2003; 21(2):163-9. PubMed ID: 12601259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum prolidase activity in patients with hypertension and its relation with left ventricular hypertrophy.
    Demirbag R; Yildiz A; Gur M; Yilmaz R; Elçi K; Aksoy N
    Clin Biochem; 2007 Sep; 40(13-14):1020-5. PubMed ID: 17604013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic and antihypertrophic microRNA levels in peripheral blood mononuclear cells and their relationship to left ventricular hypertrophy in patients with essential hypertension.
    Kontaraki JE; Marketou ME; Parthenakis FI; Maragkoudakis S; Zacharis EA; Petousis S; Kochiadakis GE; Vardas PE
    J Am Soc Hypertens; 2015 Oct; 9(10):802-810. PubMed ID: 26358152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between parathyroid hormone and left ventricular mass in moderate essential hypertension.
    Duprez D; Bauwens F; De Buyzere M; De Backer T; Kaufman JM; Van Hoecke J; Vermeulen A; Clement DL
    J Hypertens Suppl; 1991 Dec; 9(6):S116-7. PubMed ID: 1840182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.